GenericDrugs

Aurobindo Pharma Scores Major USFDA Win with Generic Tofacitinib Tablets

The Curious Case of Ozempic's Canadian Patent: A Legal Time Bomb?

TrumpRx’s Generic Drug Push Falters as Cassidy’s FDA Battle Deepens

The Generic Drug Wars: TrumpRx Enters a Crowded Arena

The Prescription Price War Just Got a New Challenger

The Great Generic Drug Revolution: Mark Cuban, 'TrumpRx,' and the Fight for Affordable Medicine

The Prescription Price Revolution: New Players Shake Up Generic Drug Market

Healthcare on Wheels: Delhi Launches Mobile Jan Aushadi Kendras for Underserved Communities

Ivermectin's Unfulfilled Promise: A Potential Cancer Drug Quashed

The Hidden Cost of Healing: Unmasking the MRP Maze in Indian Healthcare

Navigating the Storm: Why US Tariffs Might Barely Dent India's Pharma Export Prowess

A Game Changer for Health: Generic Semaglutide Slashes Prices in India, Offering New Hope

Jharkhand's Ambitious Leap: Building a Pharmaceutical Powerhouse

A Boost for Skin Health: Zydus Lifesciences Secures Key USFDA Approval

India-EFTA Trade Deal Sparks Outcry: Farmers' Body Alleges 'Surrender' to US Corporates

The 'Skinny Label' Showdown: How a Supreme Court Case Could Redefine Generics and Drug Prices

A Landmark Win for Innovation: Delhi High Court Upholds Novo Nordisk's Semaglutide Patent

The Delhi High Court's Landmark Ruling on Semaglutide: A Win for Accessibility

Major Win: Delhi High Court Greenlights Dr. Reddy's for Export-Only Weight-Loss Drug Production

Rethinking Drug Costs: Why Quick Fixes Might Hurt More Than Help

India's AIDS Fight: A Crucial Crossroads as Breakthrough Drugs Hit Patent Walls

The Promise Unfulfilled: How Red Tape and Patents Block Access to a Game-Changing HIV Prevention Tool

Unlocking Access: The Global Battle for Affordable Medicines

Unlocking Affordability: The FDA's Bold Play to Turbocharge Generic Drug Access

The Looming Storm: How Trade Tensions Could Reshape the World's Pharmacy

The Price of Pills: Can Trump's Battle for Cheaper Drugs Actually Reshape India's Pharma Future?

The Quiet Revolution: How Federal Officials Are Fighting for Cheaper Biotech Drugs

President Trump's Landmark Initiative to Tackle Skyrocketing Prescription Drug Costs

Gilead Secures Extended Runway for Blockbuster HIV Drug After Landmark Patent Settlements

America's Medicine Cabinet: Why US Dependence on Indian Pharma Has Soared by 70% Post-Pandemic

A Breath of Relief: How Trump's Drug Tariffs Spare India's Generic Pharma Giants

Trump's Tariff Tempest: Why a 100% Drug Tax Could Sink India's Pharma Giants and Ignite a US Healthcare Crisis

Trump's Bold Move: 100% Tariff on Branded Drugs Set to Shake Global Pharma, What It Means for India

India's Pharmaceutical Powerhouse Under Siege: Navigating Trump's Tariff Tempest

Trump's Tariff Twist: Generics Spared, But India's Export Horizon Remains Cloudy

Trump's Looming 100% Pharma Tariff: A Catastrophic Blow for India's Global Pharmacy?

A Game-Changer in HIV Treatment: Generic Drug Promises Unprecedented Affordability

The Enduring Saga of Drug Prices: Trump's Lingering Shadow on Healthcare Affordability

Lupin's Latest Triumph: US FDA Greenlight for HIV Drug Ignites Stock Rally